[MoneyToday] 10 years of experience in global CRO, Commit to advance ‘K-New Drugs’ into the global market
C&R Research is, without a doubt, the top Contract Research Organization (CRO) in Korea. In terms of revenue, operating profit, and the number of employees, no other company can compete. Not only is its outward growth impressive, but its “internal strength” is also robust. Recently, the company has further solidified its global expansion plans by appointing Vice President Misook Hyun, who served as the head of the Korean branch of Quintiles Korea (now IQVIA Korea) for 10 years, a global leader in the CRO field.
She expressed her ambition, saying, “By 2027, when the company celebrates its 30th anniversary, we plan to significantly increase our global clinical trials performance. We want to become a reliable partner in new drug development for domestic biopharmaceutical companies aiming for global business.”
Vice President Misook Hyun added, “C&R Research has established a management system and infrastructure capable of conducting not only domestic but also global clinical trials, thanks to years of active investment. Our goal is for all departments—including clinical trial operations, data management, statistics, and medical affairs—to work together to contribute to the advancement of Korea’s pharmaceutical and biotechnology industries.”
Please check out further details by following the link below.
